XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Operating Activities          
Net loss $ 1,752 $ (3,362) $ (29,417) $ (8,720)  
Adjustments to reconcile net loss to net cash provided by operating activities:          
Depreciation and amortization     21,279 22,056  
Impairment of goodwill     22,708    
Loss /(profit) on sale of property, plant and equipment     181 (223)  
Provision for doubtful accounts     2,089 1,238  
Warrant contra revenue 410 (0) 1,173 730  
Share-based compensation expense     447 1,151  
Deferred income taxes     1,192 209  
Share of loss / (profit) of equity accounted investees 5 16 25 (988)  
Changes in operating assets and liabilities:          
Trade accounts receivable, net     26,171 (1,529)  
Prepaid expenses and other assets, current and noncurrent     (117) (950)  
Trade accounts payable     (10,155) (5,236)  
Income taxes, net     1,300 (2,267)  
Accrued expenses and other liabilities, current and noncurrent     27,421 1,150  
Net cash generated from operating activities     64,297 6,621  
Investing Activities          
Purchases of property, plant and equipment     (10,141) (9,027)  
Proceeds from equity-accounted investees     429 1,317  
Net cash used in investing activities     (9,712) (7,710)  
Financing Activities          
Proceeds from the issuance of common stock     8,379 6,563  
Payments on long term debt     (4,200) (7,000)  
Proceeds from (payments on) other debt, net     (34,549) 5,831  
Net cash (used in) / generated from financing activities     (30,370) 5,394  
Net increase in cash and cash equivalents     24,215 4,305  
Effect of exchange rate changes on cash and cash equivalents and restricted cash     (256) (497)  
Cash and cash equivalents and restricted cash at the beginning of the period     32,626 24,569 $ 24,569
Cash and cash equivalents and restricted cash at the end of the period 56,585 28,377 56,585 28,377 32,626
Components of cash and cash equivalents and restricted cash          
Balances with banks 48,463 17,795 48,463 17,795 $ 20,464
Restricted cash 8,122 10,582 8,122 10,582  
Total cash and cash equivalents and restricted cash $ 56,585 $ 28,377 56,585 28,377  
Supplemental disclosure of Cash Flow Information          
Cash paid for Interest and other finance cost     10,392 11,179  
Cash paid for income taxes     2,752 6,740  
Non cash warrant contra revenue     1,173 730  
Non cash share-based compensation expenses     $ 447 $ 1,151